University Hospitals of Cleveland
Cleveland, Ohio, 44106, United States
NCT Number: NCT00394758
1. To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias 2. To compare healing related complications, post-operative pain, and scarring between the two procedures.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 3
Cleveland, Ohio, 44106, United States
First line of treatment for vulvar intraepithelial neoplasia (VIN) and vaginal intraepithelial neoplasia (VAIN) is not well defined. Laser vaporization and ultrasonic surgical aspiration are both accepted surgical modalities used in the treatment of vulvar and vaginal dysplasias, however no prospective study has been done to compare the two procedures. The specific aims of this research study include:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University Hospitals Cleveland Medical Center
Other
Comparison of Surgical Procedures in Vulvar and Vaginal Dysplasias
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03792516
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Baltimore, Maryland, United States
View Trial DetailsNCT03180684
Human Papillomavirus (HPV), Pre-cancerous Lesions of the Vulva
Newark, Delaware, United States
View Trial DetailsNCT03061435
Anal Cancer, Anal Dysplasia
Toronto, Ontario, Canada
View Trial DetailsNCT01134575
Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Houston, Texas, United States
View Trial Details